J. Denner
Director and Chair, Corporate Governance Committee
Pediatric
Biogen
Austria
Biography
J. Denner joined our Board of Directors in 2009. Dr. Denner serves as Chair of our Corporate Governance Committee and is a member of our Finance Committee. Dr. Denner is a founding partner and Chief Investment Officer of Sarissa Capital Management LP. Sarissa Capital focuses on improving the strategies of companies to better provide shareholder value. From 2006 to 2011, Dr. Denner served as a Senior Managing Director at Icahn Capital. Prior to that, he served as a portfolio manager at Viking Global Investors and Morgan Stanley Investment Management. Dr. Denner is also a director of The Medicines Company and Bioverativ Inc. J. Denner joined our Board of Directors in 2009. Dr. Denner serves as Chair of our Corporate Governance Committee and is a member of our Finance Committee. Dr. Denner is a founding partner and Chief Investment Officer of Sarissa Capital Management LP. Sarissa Capital focuses on improving the strategies of companies to better provide shareholder value. From 2006 to 2011, Dr. Denner served as a Senior Managing Director at Icahn Capital. Prior to that, he served as a portfolio manager at Viking Global Investors and Morgan Stanley Investment Management. Dr. Denner is also a director of The Medicines Company and Bioverativ Inc.
Research Interest
Pediatric Neurology & Diseases, Pediatric Cardiology, Pediatric Care
